Streetbeat News

Stock Prices

CALC

CalciMedica's stock is trading lower following the announcement of a $10.2 million common stock offering.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:45 pm

PLBY

PLBY Group shares rose following an equity investment by Byborg Enterprises SA, which purchased 14.9 million shares at $1.50 per unit.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:43 pm

ATOS

Atossa Therapeutics announced promising preliminary results from its Phase 2 trial of (Z)-endoxifen, showing significant efficacy and tolerability in breast cancer treatment. The findings will be presented at the RISE UP Breast Cancer Conference.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:40 pm

MOVE

Movano Health is investigating potential stock manipulation following a reverse stock split. The company is concerned about unusual trading patterns and is taking steps to address the issue.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:40 pm

AWRE

Aware shares declined following the announcement of a year-over-year decrease in Q3 EPS results.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:40 pm

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX) has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing. The company's stock maintained a closing bid price of at least $1.00 for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:40 pm

SILO

Silo Pharma has reported positive results in the sterilization and dissolution testing of its SP-26 ketamine implant. The tests showed stability and a consistent 7-day drug release, which is a promising development for the company.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:38 pm

ITRI

Itron has updated its 2024 sales forecast to a range of $2.428 billion to $2.438 billion, which is higher than its previous guidance and the consensus estimate.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:37 pm

BNGO

Bionano Genomics, Inc. (NASDAQ:BNGO) announced a $3M registered direct offering, selling shares and warrants at $0.3039 each. The offering is expected to close by October 31, 2024, with potential additional proceeds of $6M if warrants are exercised. Funds will be used for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:37 pm

UBER

Uber Technologies, Inc reported strong Q3 2024 earnings with a 20% revenue growth to $11.188 billion, beating analyst expectations. Despite positive earnings, the stock fell 7.09% premarket. Uber's CEO stated no plans for major M&A deals, focusing on organic growth.

Portfolio Pulse from Anusuya Lahiri

October 31, 2024 | 12:37 pm